ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 95 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,027,000 | -28.9% | 450,000 | 0.0% | 1.25% | -20.5% |
| Q2 2023 | $12,694,500 | +23.0% | 450,000 | -25.0% | 1.57% | -24.4% |
| Q1 2023 | $10,320,000 | -31.7% | 600,000 | -20.0% | 2.08% | -34.4% |
| Q4 2022 | $15,105,000 | +26.8% | 750,000 | +36.4% | 3.17% | +37.0% |
| Q3 2022 | $11,913,000 | +24.6% | 550,000 | +61.6% | 2.31% | +17.6% |
| Q2 2022 | $9,561,000 | -3.6% | 340,243 | +58.3% | 1.97% | -23.8% |
| Q1 2022 | $9,920,000 | -1.7% | 215,000 | +79.2% | 2.58% | -7.5% |
| Q4 2021 | $10,087,000 | +68.2% | 120,000 | +33.3% | 2.79% | +61.9% |
| Q3 2021 | $5,998,000 | -9.8% | 90,000 | -28.0% | 1.72% | -5.8% |
| Q2 2021 | $6,650,000 | +283.1% | 125,000 | +212.5% | 1.83% | +269.2% |
| Q1 2021 | $1,736,000 | – | 40,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |